Roles of an extracellular matrix (ECM) receptor and ECM processing enzymes in demyelinating canine distemper encephalitis

Deutsche Tierarztliche Wochenschrift

Volumn 113, Issue 4, 2006, Pages 151-156

  Alldinger, Susanne ^a   Groters S ^b   Miao, Q ^c   Fonfara, S ^d   Kremmer, E ^e   Baumgartner W ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b BASF SE   (Germany)

^c Nanjing Policedog Research Institute   (China)

^d UNIVERSITY OF KIEL   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Canine distemper; CD44; Demyelination; MMPs; TIMPs

Indexed keywords

CELL SURFACE RECEPTOR; EXTRACELLULAR MATRIX RECEPTOR; HERMES ANTIGEN; MATRIX METALLOPROTEINASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ASTROCYTE; BIOSYNTHESIS; CANINE DISTEMPER MORBILLIVIRUS; DEMYELINATING DISEASE; DOG; DOG DISEASE; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; UPREGULATION; VIRUS ENCEPHALITIS;

ANIMALS; ANTIGENS, CD44; ASTROCYTES; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISTEMPER; DISTEMPER VIRUS, CANINE; DOGS; ENCEPHALITIS, VIRAL; MATRIX METALLOPROTEINASES; RECEPTORS, CELL SURFACE; UP-REGULATION;

CANINE DISTEMPER VIRUS; CANIS FAMILIARIS; MEASLES VIRUS; MORBILLIVIRUS; PARAMYXOVIRIDAE;

EID: 33646826331     PISSN: 03416593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. ALLDINGER, S., BAUMGÄRTNER, W., ÖRVELL, C. (1993): Restricted expression of viral surface proteins in canine distemper encephalitis. Acta Neuropathol. 85, 635-645.
2. ALLDINGER, S., WÜNSCHMANN, A., BAUMGÄRTNER, W., VOSS, C., KREMMER, E. (1996): Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis. Acta Neuropathol. 92, 273-280.
3. ALLDINGER, S., BAUMGÄRTNER, W., KREMMER, E., FONFARA, S. (1999): Characterization of a canine CD44 specific monoclonal antibody. J. Vet. Med. A 46, 19-32.
4. ALLDINGER, S., FONFARA, S., KREMMER, E., BAUMGÄRTNER, W. (2000): Upregulation of the hyaluronate receptor CD44 in canine distemper demyelinated plaques. Acta Neuropathol. 99, 138-146.
5. ANNABI, B., THIBEAULT, S., MOUMDJIAN, R., BELIVEAU, R. (2004): Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells. J. Biol. Chem. 279, 21888-21896.
6. ANTHONY, D. C., MILLER, K. M., FEARN, S., TOWNSEND, M. J., OPDENAKKER, G., WELLS, G. M., CLEMENTS, J. M., CHANDLER, S., GEARING, A. J., PERRY, V. H. (1998): Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 87, 62-72.
7. ASHER, R., PERIDES, G., VANDERHAEGHEN, R.-R., BIGNAMI, A. (1991): Extracellular matrix of central nervous system white matter: demonstration of a hyaluronate-protein complex. J. Neurosci. Res. 28, 410-421.
8. BAKER, A. H., EDWARDS, D. R., MURPHY, G. (2002): Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell. Sci. 115, 3719-3727.
9. BANDA, M. J., WERB, Z. (1981): Mouse macrophage elastase. Purification and characterization as a metalloproteinase. Biochem. J. 193, 589-605.
10. BAR-OR, A., NUTTALL, R. K., DUDDY, M., ALTER, A., KIM, H. J., IFERGAN, I., PENNINGTON, C. J., BOURGOIN, P., EDWARDS, D. R., YONG, V. W. (2003): Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126, 2738-2749.
11. BAUMGÄRTNER, W., ALLDINGER, S. (2005): The pathogenesis of canine distemper virus induced demyelination-A biphasic process. In: LAVI, E., CONSTANTINESCU, C. S. (eds.) Experimental models of multiple sclerosis. Springer-Verlag New York, pp 871-887.
12. BEVER, C.T., ROSENBERG, G.A. (1999): Matrix metalloproteinases in multiple sclerosis-Targets of therapy or markers of injury? Neurology 53, 1380-1381.
13. BOURGUIGNON, L. Y., GUNJA-SMITH, Z., IIDA, N., ZHU, H. B., YOUNG, L. J., MULLER, W. J., CARDIFF, R. D. (1998): CD44v (3, 8-10) is involved in cytoskeletal-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell Physiol. 176, 206-215.
14. BRENNAN, F. R., O'NEILL, J. K., ALLEN, S. J., BUTTER, C., NUKI, G., BAKER, D. (1999): CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology 98, 427-435.
15. BREW, K., DINAKARPANDIAN, D., NAGASE, H. (2000): Tissue inhibitors of metallo-proteinases: evolution, structures and function. Biochim. Biophys. Acta 1477, 267-283.
16. CHANDLER, S., COATES, R., GEARING, A., LURY, J., WELLS, G., BONE, E. (1995): Matrix metalloproteinases degrade myelin basic protein. Neurosci. Lett. 201, 223-226.
17. CHANDLER, S., COSSINS, J., LURY, J., WELLS, G. (1996): Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 228, 421-429.
18. CHANDLER, S., MILLER, K. M., CLEMENTS, J. M., LURY, J., CORKILL, D., ANTHONY, D. C., ADAMS, S. E., GEARING, A. J. (1997): Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol. 72, 155-161.
19. CLEMENTS, J. M., COSSINS, J. A., WELLS, G. M. A., CORKILL, D. J., HELFRICH, K., WOOD, L. M., PIGOTT, R., STABLER, G., WARD, G. A., GEARING, A. J. H., MILLER, K. M. (1997): Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-a inhibitor. J. Neuroimmunol. 74, 85-94.
20. CRUZ, T. F., QUACKENBUSH, E. J., LETARTE, M., MOSCARELLO, M. A. (1986): Elevated levels of a glycoprotein antigen (P-80) in gray and white matter of brain from victims of multiple sclerosis. Neurochem. Res. 11, 877-889.
21. CUZNER, M. L., OPDENAKKER, G. (1999): Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94, 1-14.
22. DALCANTO, M. C., RABINOWITZ, S. G. (1982): Experimental models of virus-induced demyelination of the central nervous system. Ann. Neural. 11, 107-109.
23. DEGRENDELE, H. C., ESTESS, P., SIEGELMAN, M. H. (1997): Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278, 672-675.
24. FRISK, A. L., BAUMGÄRTNER, W., GRÖNE, A. (1999): Dominating interleukin-10 mRNA expression induction in cerebrospinal fluid cells of dogs with natural canine distemper virus induced demyelinating and nondemyelinating CNS lesions. J. Neuroimmunol. 97, 102-109.
25. GAEDKE, K., ZURBRIGGEN, A., BAUMGÄRTNER, W. (1999): Lack of correlation between virus nucleoprotein and mRNA expression and the inflammatory response in demyelinating distemper encephalitis indicates a biphasic disease process. Eur. J. Vet. Pathol. 5, 9-20.
26. GIRGRAH, N., LETARTE, M., BECKER, L. E., CRUZ, T. F., THERIAULT, E., MOSCARELLO, M. A. (1991): Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J. Neuropathol. Exp. Neurol. 50, 779-792.
27. GRABER, H. U., MÜLLER, C. F., VANDEVELDE, M., ZURBRIGGEN, A. (1995): Restricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol. 90, 312-318.
28. GRÖNE, A., ALLDINGER, S., BAUMGÄRTNER, W. (2000): Interleukin-1β, -6, -12 and tumor necrosis factor-α expression in brains of dogs with canine distemper virus infection. J. Neuroimmunol. 110, 20-30.
29. GRÖTERS, S., ALLDINGER, S., BAUMGÄRTNER, W. (2005): Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephallitis. Acta Neuropathol. 110, 369-382.
30. GRONSKI Jr., T. J., MARTIN, R. L., KOBAYASHI, D. K., WALSH, B. C., HOLMAN, M. C., HUBER, M., VAN WART, H. E., SHAPIRO, S. D. (1997): Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J. Biol. Chem. 272, 12189-12194.
31. HARTUNG, H.-P., KIESEIER, B.C. (2000): The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J. Neuroimmunol. 107, 140-147.
32. ISACKE C. M., YARWOOD, H. (2002): The hyaluronan receptor, CD44. Int. J. Biochem. Cell. Biol. 34, 718-721.
33. KAJITA, M., ITOH, Y., CHIBA, T., MORI, H., OKADA, A., KINOH, H., SEIKI, M. (2001) Membrane-type1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153, 893-904.
34. KHUTH, S.-T., AKAOKA, H., PAGENSTECHER, A., VERLAETEN, O., BELIN, M.-F., GIRAUDON, P., BERNARD, A. (2001): Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J. Virol. 75, 8268-8282.
35. KIESEIER, B. C., PAUL, R., KOEDEL, U., SEIFERT, T., CLEMENTS, J. M., GEARING, A. J., PFISTER, H. W., HARTUNG, H. P. (1999): Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122, 1579-1587.
36. KOUWENHOVEN, M., OZENCI, V., GOMES, A., YARILIN, D., GIEDRAITIS, V., PRESS, R., LINK, H. (2001): Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J. Autoimmun. 16, 463-470.
37. LARSEN, P. H., YONG, V. W. (2004): The expression of matrix metalloprotein-ase-12 by oligodendrocytes regulates their matura-tion and morphological differentiation. J. Neurosci. 24, 7597-7603.
38. LEPPERT, D., FORD, J., STABLER, G., GRYGAR, C., LIENERT, C., HUBER, S., MILLER, K. M., HAUSER, S. L., KAPPOS, L. (1998): Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121, 2327-2334.
39. LEPPERT, D., LINDBERG, R. L., KAPPOS, L., LEIB, S. L. (2001): Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Rev. 36, 249-257.
40. LINDBERG, R.L.P., DE GROOT, C.J.A., MONTAGNE, L. FREITAG, P., VAN DER VALK, P., KAPPOS, L., LEPPERT, D. (2001): The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124, 1743-1753.
41. LO, E. H., WANG, X., CUZNER, M. L. (2002): Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J. Neuro-sci. Res. 69, 1-9.
42. MARKUS, S., FAILING, K., BAUMGÄRTNER, W. (2002): Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. J. Neuroimmunol. 125, 30-41.
43. MATYSZAK, M. K., PERRY, V. H. (1996): Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J. Neuroimmunol. 69, 141-149.
44. McKEE, C. M., PENNO, M. B., COWMAN, M., BURDICK, M. D., STRIETER, R. M., BAO, C., NOBLE, P. W. (1996): Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98, 2403-2413.
45. MIAO, Q., BAUMGÄRTNER, W., FAILING, K., ALLDINGER, S. (2003): Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis. Acta Neuropathol. 106, 486-494.
46. MUN-BRYCE, S., ROSENBERG, G. A. (1998): Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274, R1203-1211.
47. MUTINELLI, F., VANDEVELDE, M., GRIOT, C., RICHARD, A. (1988): Astrocytic infection in canine distemper virus-induced demyelination. Acta Neuropathol. 77, 333-335.
48. NAGASE, H., WOESSNER Jr., J. F. (1999): Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
49. NOBLE, P. W., LAKE, F. R., HENSON, P. M., RICHES, D. W. (1993): Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J. Clin. Invest. 91, 2368-2377.
50. OZENCI, V., RINALDI, L., TELESHOVA, N., MATUSEVICIUS, D., KIVISAKK, P., KOUWENHOVEN, M., LINK, H. (1999). Metalloproteinases and their tissue inhibitors in multiple sclerosis. J. Autoimmun. 12, 297-303.
51. OH, J., TAKAHASHI, R., KONDO, S., MIZOGUCHI, A., ADACHI, E., SASAHARA, R.M., NISHIMURA, S., IMAMURA, Y., HITAYAMA, H., ALEXANDER, D. B., IDE, C., HORAN, T.P., ARAKAWA, T., YOSHIDA, H., NISHIKAWA, S., ITOH, Y., SEIKI, M., ITOHARA, S., TAKAHASHI, C., NODA, M. (2001): The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107, 789-800.
52. PAGENSTECHER, A., STALDER, A. K., KINCAID, C. L., SHAPIRO, S. D., CAMPBELL, I.L (1998): Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 152, 729-741.
53. st edn. Academic Press, San Diego, pp 549-561.
54. RIES, C., PETRIDES, P.E. (1995): Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler 376, 345-355.
55. ROSENBERG, G. A., KORNFELD, M., ESTRADA, E., KELLEY, R. O. LIOTTA, L. A., STETLER-STEVENSON, W. G. (1992): TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 576, 203-207.
56. ROSENBERG, G. A., CUNNINGHAM, L. A., WALLACE, J. (2001): Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893, 104-112.
57. ROSENBERG, G. A. (2002): Matrix metalloproteinases in neuroinflammation. Glia 39, 279-291.
58. STERNLICHT, M. D., WERB, Z. (2001): How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
59. TAKAHASHI, K., ETO, H., TANABE, K. K. (1999): Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int. J. Cancer 80, 387-395.
60. TIPOLD, A., MOORE, P., ZURBRIGGEN, A., BURGENER, I., BARBEN, G., VANDEVELDE, M. (1999): Early T cell response in the central nervous system in canine distemper virus infection. Acta Neuropathol. 97, 45-56.
61. TOFT-HANSEN, H., NUTTALL, R. K., EDWARDS, D. R., OWENS, T. (2004): Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J. Immunol. 173, 5209-5218.
62. ULRICH, R., GERHAUSER, I., SEELIGER, F., BAUMGÄRTNER, W., ALLDINGER, S. (2005): Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: A reverse transcription quantitative polymerase chain reaction study. Dev. Neuroci. 27, 408-418.
63. VISSE, R., NAGASE, H. (2003): Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
64. VOS, C. M. P., VAN HAASTERT, E. S., DE GROOT, C. J. A., VAN DER VALK, P., DE VRIES, H. (2003): Matrix metalloproteinase-12 is expressed in phagocytic macrophages in active multiple sclerosis lesions. J. Neuroimmunol. 138, 106-114.
65. YU, Q., STAMENKOVIC, I. (1999): Localisation of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13, 48-54.
66. YU, Q., STAMENKOVIC, I. (2000): Cell surface-localised matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176.
67. WELLS, G. M., CATUN, G., COSSINS, J. A., MANGAN, M., WARD, G. A., MILLER, K. M., CLEMENTS, J. M. (1996). Quantitation of matrix metalloproteinases in cultured rat astrocytes using polymerase chain reaction with a multi-competitor cDNA standard. Glia 18, 332-340.
68. WOESSNER Jr., J. F. (2002): MMPs and TIMPs-an historical perspective. Mol. Biotechnol. 22, 33-49.
69. WÜNSCHMANN, A., ALLDINGER, S., KREMMER, E., BAUMGÄRTNER, W. (1999): Identification of CD4+ and CD8+ T cell subsets and B cells in the brain of dogs with spontaneous acute, subacute- and chronic-demyelinating distemper encephalitis. J. Vet. Immunol. Immunopathol. 67, 101-116.
70. YONG, V. W., POWER, C., FORSYTH, P., EDWARDS, D. R. (2001): Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511.
71. YU, W. H., WOESSNER Jr., J. F., Mc NEISH, J. D., STAMENKOVIC, I. (2002): CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodelling. Genes Dev. 16, 307-323.
72. ZURBRIGGEN, A., SCHMID, I., GRABER, H.U., VANDEVELDE, M. (1998): Oligodendroglial pathology in canine distemper. Acta Neuropathol. 95, 71-77.